Core Viewpoint - The company emphasizes its commitment to quality management throughout the entire service cycle of product development, production, and delivery in the pharmaceutical sector [1] Group 1: Quality Management Systems - The company has established an ISO management system at its domestic production base, which has been continuously certified [1] - The company's U.S. production base has implemented a cGMP system and has passed inspections by drug regulatory agencies in the U.S. and Japan [1] - The development of these quality systems is fundamental for the company to be recognized as a qualified supplier by international pharmaceutical enterprises [1]

Core Viewpoint - The company is actively exploring technological improvements in synthetic biology applications for pharmaceutical intermediates and active pharmaceutical ingredients to reduce production costs and environmental pollution [2] Group 1 - The company is focusing on technological exploration in synthetic biology [2] - The aim is to lower production costs [2] - The initiative also targets the reduction of environmental pollution [2]